Three years ago, the FDA found so many violations at a Nephron Pharmaceuticals manufacturing facility that the U.S. | Nephron Pharmaceuticals' manufacturing facility in West Columbia, South Carolina, ...
The purpose of this communication is to present certain data pertinent to this syndrome and to suggest that treatment based on the pathological physiology of this type of renal failure offers ...
A recent inspection at a South Carolina drug production facility flagged several problems with how the company was producing drugs for the mass market, little more than a year after the same facility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback